Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer - long term results.

Abstract

The combination of HDRB and HypoRT is well tolerated, with acceptable toxicity rates. Furthermore, results from rebiopsies revealed an encouraging rate of local control.

These results confirm that the use of conformal RT techniques, adapted to specific biological tumor characteristics, have the potential to improve the therapeutic ratio in intermediate-risk PC patients.

Full Text

• DOI - (DOI)
• Swets Information Services - full-text online
• OhioLINK Electronic Journal Center - full-text online
• Elsevier Science - full-text online
• EBSCO - full-text online

Temas

• Anciano
• Biopsia
• Braquiterapia
• Supervivencia Sin Enfermedad
• Fraccionamiento De La Dosis
• Estudios De Seguimiento
• Gastrointestinal Tract
• Humanos
• Varón
• Middle Aged
• Prostata
• Antigeno Prostatico Especifico
• Neoplasmas De La Prostata
• Traumatismos Por Radiacion
• Riesgo
• Sistema Urogenital

Artículos similares

• [Efficacy of European Organization for Research and Treatment of Cancer (EORTC) risk tables for the prediction of recurrence and progression of non-muscle invasive bladder cancer after intravesical pirarubicin instillation]. (2012-11-19)
• Validation of the GRACE risk score to predict in-hospital mortality in patients with ST segment elevation myocardial infarction in Thailand. (2013-04-17)
• Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience. (2013-02-07)
• High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy. (2011-12-22)
• Incremental diagnostic value of circulating pentraxin in patients with intermediate risk of coronary artery disease. (2013-03-06)
• High response rate for treatment with gemtuzumab ozogamicin and cytarabine in elderly patients with acute myeloid leukemia and favorable and intermediate-I cytogenetic risk. (2012-09-25)
• The learning curve for laparoscopic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer: implications for compliance with existing guidelines. (2013-02-18)
• Detecting sodium-sensitivity in hypertensive patients: information from 24-hour ambulatory blood pressure monitoring. (2011-01-20)
• [Application of perioperative imatinib mesylate therapy in initial resectable primary local advanced gastrointestinal stromal tumor at intermediate or high risk]. (2013-03-28)
• The value of perioperative mitomycin C instillation in improving subsequent bacillus calmette-guerin instillation efficacy in intermediate and high-risk patients with non-muscle invasive bladder cancer: a prospective randomized study. (2012-07-27)

Autores

• Fabio L Cury
• Marie Duclos
• Armen Aprikian
• Horacio Patrocinio
• Wassim Kassouf
• George Shenouda
• Sergio Faria
• Marc David
• Luis Souhami

Fecha de publicación

2012-03-05

Revista

Temas de la revista

• Radiobiologia

Idioma

Eng.

Copyright

Department of Radiation Oncology, McGill University Health Centre, Montreal, QC, Canada. fabio.cury [at] muhc.mcgill.ca

Referencia de entrega

Int J Radiat Oncol Biol Phys. 2012 Mar;82(4):1417-23

Libros relacionados

• Books of Antigeno Prostatico Especifico
• Books of Biopsia
• Books of Braquiterapia
• Books of Estudios De Seguimiento
• Books of Fraccionamiento De La Dosis
• Books of Gastrointestinal Tract
• Books of Neoplasmas De La Prostata
• Books of Prostata
• Books of Radiobiologia
• Books of Sistema Urogenital
• Books of Supervivencia Sin Enfermedad
• Books of Traumatismos Por Radiacion